Tech Company Financing Transactions
NorthStar Medical Technologies Funding Round
On 10/2/2026, NorthStar Medical Technologies raised $185 million in financing from Hercules Capital.
Transaction Overview
Company Name
Announced On
10/2/2026
Transaction Type
Debt
Amount
$185,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1800 Gateway Boulevard
Beloit, WI 53511
USA
Beloit, WI 53511
USA
Phone
Website
Email Address
Not Recorded
Overview
NorthStar is a radiopharmaceutical company, developing novel ways to help detect and cure cancer and other serious diseases. We are the first and only U.S. company housing commercial scale radioisotope production and radiopharmaceutical CDMO services co-located on the same campus. We are routinely producing radioisotopes including Actinium-225 (Ac-225) and Copper-67 (Cu-67), used in drug development and clinical trials for the treatment of several types of cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Frank Scholz
Chief Financial Officer
Victor Miller
Chief Scientific Officer
James Harvey
Chief Technical Officer
Jeff Schaaf
VP - Bus. Development
Gauri Gupta
VP - Bus. Development
Kathy Spencer-Pike
VP - Finance
Alison Hess
VP - Human Resources
Chris Hart
VP - Operations
Jean-Noel David
Browse more venture capital transactions:
Prev: 10/2/2026: Aignosis venture capital transaction
Next: 10/2/2026: SedMed venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on funding rounds that are announced publicly. VC transactions reported here are derived from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs